Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026)

Hims & Hers Health (HIMS) reported Change in Accured Expenses of $10.0 million for Q1 2026, up 130.2% on a YoY basis from $4.4 million in Q1 2025, and up 625.22% sequentially from -$1.9 million in Q4 2025.

Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 8 years of Change in Accured Expenses data on file, last reported at $10.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses rose 130.2% year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at -$37.4 million (down 222.99% YoY), and the FY2025 full-year result was -$43.1 million, down 280.96% from the prior year.
  • Change in Accured Expenses rose to $10.0 million in Q1 2026, from -$1.9 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $14.0 million in Q3 2024 to a low of -$52.9 million in Q3 2025.
  • A 5-year average of $481588.2 and a median of $3.3 million in 2022 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses slumped 565.29% in 2022 and soared 507.26% in 2024, its largest moves.
  • Tracing HIMS's Change in Accured Expenses over 5 years: stood at -$4.6 million in 2022, then surged by 134.96% to $1.6 million in 2023, then soared by 507.26% to $9.8 million in 2024, then slumped by 119.48% to -$1.9 million in 2025, then surged by 625.22% to $10.0 million in 2026.
  • Business Quant data shows HIMS's Change in Accured Expenses at $10.0 million in Q1 2026, -$1.9 million in Q4 2025, and -$52.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -144.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn 10.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.02 Mn
Mar 31, 2026 10.02 Mn
Dec 31, 2025 -1.91 Mn
Dec 31, 2025 -1.91 Mn
Sep 30, 2025 -52.88 Mn
Sep 30, 2025 -52.88 Mn
Jun 30, 2025 7.39 Mn
Jun 30, 2025 7.39 Mn
Mar 31, 2025 4.35 Mn
Mar 31, 2025 4.35 Mn
Dec 31, 2024 9.79 Mn
Dec 31, 2024 9.79 Mn
Sep 30, 2024 14.03 Mn
Sep 30, 2024 14.03 Mn
Jun 30, 2024 2.23 Mn
Jun 30, 2024 2.23 Mn
Mar 31, 2024 -2.26 Mn
Mar 31, 2024 -2.26 Mn
Dec 31, 2023 1.61 Mn
Dec 31, 2023 1.61 Mn